Is glyceryl trinitrate (GTN) safe to give to a haemodynamically stable patient with atrial fibrillation for relief of myocardial ischemia?

Is GTN Safe in Atrial Fibrillation?

Yes, glyceryl trinitrate (GTN) is safe to administer to hemodynamically stable patients with atrial fibrillation for relief of myocardial ischemia, provided systolic blood pressure remains ≥90–100 mmHg and the patient does not have right ventricular infarction. 1

---

Hemodynamic Precautions

• GTN is contraindicated when systolic blood pressure is <90 mmHg or has dropped ≥30 mmHg below baseline, because nitrates can precipitate severe hypotension in this setting. 1

• Extreme bradycardia (<50 bpm) or tachycardia (>100 bpm) in the absence of heart failure are relative contraindications to GTN administration. 1

• Right ventricular infarction is an absolute contraindication to nitrate therapy; always obtain a right-sided ECG in patients with inferior wall STEMI before administering GTN. 1

• Hypotension induced by GTN may be accompanied by paradoxical bradycardia and worsening angina, particularly in volume-depleted patients. 2

---

Administration Protocol for Ischemic Chest Pain

• Give up to 3 doses of sublingual or aerosol GTN at 3- to 5-minute intervals until pain is relieved or blood pressure limits further use. 1

• GTN spray (400 mcg, or 2 puffs) can be administered every 5–10 minutes while monitoring blood pressure continuously. 1

• If systolic blood pressure falls below 90–100 mmHg, reduce the GTN dose; discontinue permanently if blood pressure drops further. 1

• From a practical standpoint, aim for a reduction of 10 mmHg in mean arterial pressure as the therapeutic target. 1

---

Atrial Fibrillation–Specific Considerations

Rate Control Takes Priority

• In hemodynamically stable AF with ischemia, initiate rate control with IV beta-blockers (metoprolol 2.5–5 mg IV) or non-dihydropyridine calcium-channel blockers (diltiazem 0.25 mg/kg IV) as first-line therapy while simultaneously administering GTN for anginal relief. 1

• For patients with reduced ejection fraction (LVEF ≤40%), use only beta-blockers and/or digoxin for rate control; avoid calcium-channel blockers because of negative inotropic effects. 1, 3

• Target a lenient resting heart rate <110 bpm initially; pursue stricter control (<80 bpm) only if symptoms persist. 4, 3

Hemodynamic Instability Mandates Cardioversion

• If the patient develops symptomatic hypotension, acute heart failure, ongoing chest pain, or altered mental status despite GTN and rate control, perform immediate synchronized electrical cardioversion (≥200 J biphasic) without awaiting anticoagulation. 1, 5

---

Evidence Limitations and Clinical Context

• No conclusive evidence supports routine use of IV, oral, or topical nitrate therapy in acute myocardial infarction; treatment benefits are limited. 1

• GTN should be carefully considered when its use would preclude administration of agents with proven mortality benefit, such as ACE inhibitors. 1

• Rapid tolerance develops with IV GTN, especially at high doses, limiting effectiveness to 16–24 hours only. 1

• Inappropriate vasodilation may induce a steep reduction in blood pressure, resulting in hemodynamic instability. 1

---

Common Pitfalls to Avoid

• Do not administer GTN to patients with suspected right ventricular infarction (perform right-sided ECG in all inferior STEMI cases). 1

• Do not give GTN when systolic blood pressure is <90 mmHg or has dropped ≥30 mmHg below baseline. 1

• Avoid GTN in patients with severe aortic stenosis, although it may help in complex situations when used with extreme caution. 1

• Do not delay rate control or cardioversion while administering GTN; ischemia in AF often results from inadequate rate control rather than coronary occlusion. 1

• Excessive GTN dosage may produce severe headaches; use the smallest effective dose. 2

---

Drug Interactions

• Concomitant use of GTN with soluble guanylate cyclase stimulators is contraindicated. 2

• Concomitant use of nitrates and alcohol may cause hypotension. 2

• Aspirin may enhance the vasodilatory and hemodynamic effects of GTN. 2

• Sublingual GTN during alteplase therapy requires caution, as IV nitroglycerin decreases the thrombolytic effect of alteplase. 2

---

Anticoagulation Remains Mandatory

• Initiate oral anticoagulation immediately for all AF patients with CHA₂DS₂-VASc score ≥2 (men) or ≥3 (women), regardless of rate control or GTN administration. 1, 3

• Direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran) are preferred over warfarin except in mechanical valves or moderate-to-severe mitral stenosis. 1, 3

• For AF lasting >48 hours or unknown duration, provide therapeutic anticoagulation for ≥3 weeks before any elective cardioversion and continue for ≥4 weeks afterward. 1, 3